Estimate Recalculated Feb 7, 2025 09:31PM EST
Robert B Bazemore does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Neon Therapeutics, Inc., ARDELYX, INC., Epizyme, Inc., and SYNAGEVA BIOPHARMA CORP.
Robert B Bazemore's CIK is 0001620152
2020 was Robert B Bazemore's most active year for acquiring shares with 9 total transactions. Robert B Bazemore's most active month to acquire stocks was the month of May. 2020 was Robert B Bazemore's most active year for disposing of shares, totalling 13 transactions. Robert B Bazemore's most active month to dispose stocks was the month of May. 2020 saw Robert B Bazemore paying a total of $89,800.00 for 552,103 shares, this is the most they've acquired in one year. In 2020 Robert B Bazemore cashed out on 280,436 shares for a total of $765,340.55, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!